Cargando…

Evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study

BACKGROUND: Guidelines recommend screening of high-risk women using breast magnetic resonance imaging (MRI). Contrast-enhanced mammography (CEM) has matured, providing excellent diagnostic accuracy. To lower total radiation dose, evaluation of single-view (1 V) CEM exams might be considered instead...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobbes, M. B. I., Hecker, J., Houben, I. P. L., Pluymakers, R., Jeukens, C., Laji, U. C., Gommers, S., Wildberger, J. E., Nelemans, P. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795610/
https://www.ncbi.nlm.nih.gov/pubmed/31073859
http://dx.doi.org/10.1007/s00330-019-06215-7
_version_ 1783459475492962304
author Lobbes, M. B. I.
Hecker, J.
Houben, I. P. L.
Pluymakers, R.
Jeukens, C.
Laji, U. C.
Gommers, S.
Wildberger, J. E.
Nelemans, P. J.
author_facet Lobbes, M. B. I.
Hecker, J.
Houben, I. P. L.
Pluymakers, R.
Jeukens, C.
Laji, U. C.
Gommers, S.
Wildberger, J. E.
Nelemans, P. J.
author_sort Lobbes, M. B. I.
collection PubMed
description BACKGROUND: Guidelines recommend screening of high-risk women using breast magnetic resonance imaging (MRI). Contrast-enhanced mammography (CEM) has matured, providing excellent diagnostic accuracy. To lower total radiation dose, evaluation of single-view (1 V) CEM exams might be considered instead of double-view (2 V) readings as an alternative reading strategy in women who cannot undergo MRI. METHODS: This retrospective non-inferiority feasibility study evaluates whether the use of 1 V results in an acceptable sensitivity for detecting breast cancer (non-inferiority margin, − 10%). CEM images from May 2013 to December 2017 were included. 1 V readings were performed by consensus opinion of three radiologists, followed by 2 V readings being performed after 6 weeks. Cases were considered “malignant” if the final BI-RADS score was ≥ 4, enabling calculation of sensitivity, specificity, and area under the receiver operating characteristic curve (AUC). Histopathological results or follow-up served as a gold standard. RESULTS: A total of 368 cases were evaluated. Mean follow-up for benign or negative cases was 20.9 months. Sensitivity decreased by 9.6% from 92.9 to 83.3% when only 1 V was used for evaluation (p < 0.001). The lower limit of the 90% confidence interval around the difference in sensitivity between 1 V and 2 V readings was − 15% and lies below the predefined non-inferiority margin of − 10%. Hence, non-inferiority of 1 V to 2 V reading cannot be concluded. AUC for 1 V was significantly lower, 0.861 versus 0.899 for 2 V (p = 0.0174). CONCLUSION: Non-inferiority of 1 V evaluations as an alternative reading strategy to standard 2 V evaluations could not be concluded. 1 V evaluations had lower diagnostic performance compared with 2 V evaluations. KEY POINTS: • To lower radiation exposure used in contrast-enhanced mammography, we studied a hypothetical alternative strategy: single-view readings (1 V) versus (standard) double-view readings (2 V). • Based on our predefined margin of − 10%, non-inferiority of 1 V could not be concluded. • 1 V evaluation is not recommended as an alternative reading strategy to lower CEM-related radiation exposure.
format Online
Article
Text
id pubmed-6795610
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-67956102019-10-25 Evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study Lobbes, M. B. I. Hecker, J. Houben, I. P. L. Pluymakers, R. Jeukens, C. Laji, U. C. Gommers, S. Wildberger, J. E. Nelemans, P. J. Eur Radiol Breast BACKGROUND: Guidelines recommend screening of high-risk women using breast magnetic resonance imaging (MRI). Contrast-enhanced mammography (CEM) has matured, providing excellent diagnostic accuracy. To lower total radiation dose, evaluation of single-view (1 V) CEM exams might be considered instead of double-view (2 V) readings as an alternative reading strategy in women who cannot undergo MRI. METHODS: This retrospective non-inferiority feasibility study evaluates whether the use of 1 V results in an acceptable sensitivity for detecting breast cancer (non-inferiority margin, − 10%). CEM images from May 2013 to December 2017 were included. 1 V readings were performed by consensus opinion of three radiologists, followed by 2 V readings being performed after 6 weeks. Cases were considered “malignant” if the final BI-RADS score was ≥ 4, enabling calculation of sensitivity, specificity, and area under the receiver operating characteristic curve (AUC). Histopathological results or follow-up served as a gold standard. RESULTS: A total of 368 cases were evaluated. Mean follow-up for benign or negative cases was 20.9 months. Sensitivity decreased by 9.6% from 92.9 to 83.3% when only 1 V was used for evaluation (p < 0.001). The lower limit of the 90% confidence interval around the difference in sensitivity between 1 V and 2 V readings was − 15% and lies below the predefined non-inferiority margin of − 10%. Hence, non-inferiority of 1 V to 2 V reading cannot be concluded. AUC for 1 V was significantly lower, 0.861 versus 0.899 for 2 V (p = 0.0174). CONCLUSION: Non-inferiority of 1 V evaluations as an alternative reading strategy to standard 2 V evaluations could not be concluded. 1 V evaluations had lower diagnostic performance compared with 2 V evaluations. KEY POINTS: • To lower radiation exposure used in contrast-enhanced mammography, we studied a hypothetical alternative strategy: single-view readings (1 V) versus (standard) double-view readings (2 V). • Based on our predefined margin of − 10%, non-inferiority of 1 V could not be concluded. • 1 V evaluation is not recommended as an alternative reading strategy to lower CEM-related radiation exposure. Springer Berlin Heidelberg 2019-05-09 2019 /pmc/articles/PMC6795610/ /pubmed/31073859 http://dx.doi.org/10.1007/s00330-019-06215-7 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Breast
Lobbes, M. B. I.
Hecker, J.
Houben, I. P. L.
Pluymakers, R.
Jeukens, C.
Laji, U. C.
Gommers, S.
Wildberger, J. E.
Nelemans, P. J.
Evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study
title Evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study
title_full Evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study
title_fullStr Evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study
title_full_unstemmed Evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study
title_short Evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study
title_sort evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study
topic Breast
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795610/
https://www.ncbi.nlm.nih.gov/pubmed/31073859
http://dx.doi.org/10.1007/s00330-019-06215-7
work_keys_str_mv AT lobbesmbi evaluationofsingleviewcontrastenhancedmammographyasnovelreadingstrategyanoninferiorityfeasibilitystudy
AT heckerj evaluationofsingleviewcontrastenhancedmammographyasnovelreadingstrategyanoninferiorityfeasibilitystudy
AT houbenipl evaluationofsingleviewcontrastenhancedmammographyasnovelreadingstrategyanoninferiorityfeasibilitystudy
AT pluymakersr evaluationofsingleviewcontrastenhancedmammographyasnovelreadingstrategyanoninferiorityfeasibilitystudy
AT jeukensc evaluationofsingleviewcontrastenhancedmammographyasnovelreadingstrategyanoninferiorityfeasibilitystudy
AT lajiuc evaluationofsingleviewcontrastenhancedmammographyasnovelreadingstrategyanoninferiorityfeasibilitystudy
AT gommerss evaluationofsingleviewcontrastenhancedmammographyasnovelreadingstrategyanoninferiorityfeasibilitystudy
AT wildbergerje evaluationofsingleviewcontrastenhancedmammographyasnovelreadingstrategyanoninferiorityfeasibilitystudy
AT nelemanspj evaluationofsingleviewcontrastenhancedmammographyasnovelreadingstrategyanoninferiorityfeasibilitystudy